Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes

被引：0
作者：
Masahiko Sugimoto
Chiharu Handa
Kazufumi Hirano
Toshiyuki Sunaya
Mineo Kondo
机构：
[1] Mie University Graduate School of Medicine,Department of Ophthalmology
[2] Bayer Yakuhin,Medical Affairs & Pharmacovigilance
[3] Ltd.,Research & Development Japan
[4] Bayer Yakuhin,undefined
[5] Ltd.,undefined
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2022年 / 260卷
关键词：
Diabetic macular edema; Intravitreal aflibercept; Anti-vascular endothelial growth factor treatment; Real-world clinical practice;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3489 / 3498
页数：9
相关论文
共 50 条
  • [21] Switching to intravitreal fluocinolone acetonide implant for refractory diabetic macular edema: 12-and 24-month results
    Chronopoulos, Argyrios
    Chronopoulos, Panagiotis
    Ashurov, Agharza
    Korb, Christina
    Pfeiffer, Norbert
    Hattenbach, Lars-Olof
    [J]. EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2022, 32 (01) : 443 - 449
  • [22] Visual and Anatomical Outcomes of a Single Intravitreal Dexamethasone in Diabetic Macular Edema: An 8 Year Real-World Study
    Faes, Livia
    Mishra, Amit V.
    Lipkova, Veronika
    Balaskas, Konstantinos
    Quek, Chrystie
    Hamilton, Robin
    Held, Ulrike
    Sim, Dawn
    Sivaprasad, Sobha
    Fu, Dun Jack
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [23] Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study
    Han, Ye Eun
    Jo, Jaehyuck
    Kim, Yoon Jeon
    Lee, Junyeop
    [J]. JOURNAL OF DIABETES RESEARCH, 2023, 2023
  • [24] Influence of prior treatment protocol on intravitreal dexamethasone implant behavior in patients with diabetic macular edema in real-world practice
    Moreno-Martinez, Almudena
    Blanco-Marchite, Cristina
    Copete, Sergio
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024, 23 (02) : 199 - 205
  • [25] Aflibercept for clinically significant diabetic macular edema: 12-month results in daily clinical practice
    Campos Polo, Rafael
    Rubio Sanchez, Consuelo
    Garcia Guisado, Diego Manuel
    Diaz Luque, Maria Jose
    [J]. CLINICAL OPHTHALMOLOGY, 2018, 12 : 99 - 104
  • [26] Aflibercept for Diabetic Macular Edema in Real-Life Practice in GREece: Three-Year Outcomes of the ADMIRE Study
    Chatziralli, Irini
    Agapitou, Chrysa
    Dimitriou, Eleni
    Kapsis, Petros
    Kazantzis, Dimitrios
    Machairoudia, Genovefa
    Georgiadis, Odysseas
    Theodossiadis, George
    Theodossiadis, Panagiotis
    [J]. SEMINARS IN OPHTHALMOLOGY, 2024, 39 (01) : 96 - 101
  • [27] The effects of epiretinal membranes on the treatment outcomes of intravitreal aflibercept injection in diabetic macular edema: a real-life study
    Kocak Altintas, Ayse Gul
    Ilhan, Cagri
    Cankurtaran, Mahmut
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (10) : 2635 - 2641
  • [28] Real-life outcomes of intravitreal ranibizumab, aflibercept, and dexamethasone implant administrations in patients with treatmentnaive diabetic macular edema
    Korkmaz, Anil
    Karti, Omer
    Zengin, Mehmet O.
    Yuksel, Bora
    Kusbeci, Tuncay
    [J]. SAUDI JOURNAL OF OPHTHALMOLOGY, 2022, 36 (03) : 327 - 334
  • [29] The effects of epiretinal membranes on the treatment outcomes of intravitreal aflibercept injection in diabetic macular edema: a real-life study
    Ayse Gul Kocak Altintas
    Cagri Ilhan
    Mahmut Cankurtaran
    [J]. International Ophthalmology, 2020, 40 : 2635 - 2641
  • [30] Haller Layer Thickness after Intravitreal Aflibercept Injection in Diabetic Macular Edema: 1 Month Change
    Sung, Su Min
    Lee, Kyoo Won
    Kang, Hyun Gu
    [J]. JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2022, 63 (12): : 973 - 983
12345